Cargando…

Need for risk adjustment in comparative effectiveness and cost-effectiveness studies in r/r follicular lymphoma

Detalles Bibliográficos
Autores principales:	Gribben, John, Palomba, M. Lia, Patel, Anik R., Nahas, Myrna, Neelapu, Sattva S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248088/ https://www.ncbi.nlm.nih.gov/pubmed/36661331 http://dx.doi.org/10.1182/bloodadvances.2022009469

Ejemplares similares

Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma
por: Ghione, Paola, et al.
Publicado: (2022)

Therapy of newly diagnosed follicular lymphoma
por: Westin, Jason R., et al.
Publicado: (2012)

Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study
por: Ghione, Paola, et al.
Publicado: (2022)

The combination of ibrutinib and rituximab demonstrates activity in first‐line follicular lymphoma
por: Fowler, Nathan H., et al.
Publicado: (2020)

Anti-PD-1 antibodies for the treatment of B-cell lymphoma: Importance of PD-1(+) T-cell subsets
por: Chu, Fuliang, et al.
Publicado: (2014)

Therapeutic Vaccine for Lymphoma
por: Lee, Seung-Tae, et al.
Publicado: (2007)

Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma
por: Nastoupil, Loretta J., et al.
Publicado: (2022)

Commentary: High fidelity and cost-effective cataract surgery training system: Need of the hour
por: Moharana, Bruttendu, et al.
Publicado: (2021)

Hodgkin Lymphoma Untreated for Six Years Presenting with Tracheoesophageal Fistula
por: Westin, Jason R., et al.
Publicado: (2012)

R-CHOP versus R-CVP in the treatment of follicular lymphoma: a meta-analysis and critical appraisal of current literature
por: Siddhartha, Ganguly, et al.
Publicado: (2009)

Risk‐adapted therapy in follicular lymphoma: Is it time to “FLEX”?
por: Tobin, Joshua W. D., et al.
Publicado: (2020)

Mutational patterns along different evolution paths of follicular lymphoma
por: Michaeli, Miri, et al.
Publicado: (2022)

PET-Based Staging Is Cost-Effective in Early-Stage Follicular Lymphoma
por: Lo, Andrea C., et al.
Publicado: (2022)

Molecular evidence of Zn chelation of the procaspase activating compound B-PAC-1 in B cell lymphoma
por: Sarkar, Aloke, et al.
Publicado: (2015)

Commentary: Evaluating affordability, cost-effectiveness, cost-utility, health economics, and incremental cost-effectiveness ratio of manual small-incision cataract surgery - The need of the hour
por: Tejaswini, Antarvedi, et al.
Publicado: (2022)

Hedgehog inhibitors selectively target cell migration and adhesion of mantle cell lymphoma in bone marrow microenvironment
por: Zhang, Han, et al.
Publicado: (2016)

“Triaging” Chronic Migraine Patients in Need of CGRP(r) Monoclonal Antibodies
por: Martelletti, Paolo
Publicado: (2020)

P1092: A PHASE II INVESTIGATOR INITIATED STUDY OF ACALABRUTINIB, LENALIDOMIDE AND RITUXIMAB (AR2) IN PATIENTS WITH PREVIOUSLY UNTREATED HIGH TUMOR BURDEN FOLLICULAR LYMPHOMA
por: Strati, Paolo, et al.
Publicado: (2023)

Cost-effectiveness of obinutuzumab versus rituximab biosimilars for previously untreated follicular lymphoma
por: Spencer, Scott J, et al.
Publicado: (2021)

Cost Analysis of R-CHOP Versus Dose-Adjusted R-EPOCH in Treatment of Diffuse Large B-Cell Lymphoma with High-Risk Features
por: Dholaria, Bhagirathbhai, et al.
Publicado: (2020)

Covid-19 pandemic, R&D, vaccines, and the urgent need of UBUNTU practice
por: Homma, Akira, et al.
Publicado: (2021)

CXCR5+CD8+ T cells are localized in B cell follicles and germinal centers and exhibit regulatory and anti-tumor function
por: Chu, Fuliang, et al.
Publicado: (2015)

Cost-effectiveness of HIV Prevention Interventions: Estimates from Real-world Implementation Needed
por: Peebles, Kathryn, et al.
Publicado: (2019)

Is Metabolism of (R)-Ketamine Essential for the Antidepressant Effects?
por: Chaki, Shigeyuki
Publicado: (2017)

Is there a role for allogeneic hematopoietic stem cell transplantation for refractory follicular lymphoma?
por: Yang, Yang, et al.
Publicado: (2022)

Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphoma
por: Strati, Paolo, et al.
Publicado: (2020)

Balancing considerations and qualifying conclusions for cost-effectiveness of therapies for relapsed/refractory follicular lymphoma
por: Potnis, Kunal C., et al.
Publicado: (2023)

Expression of BAFF and BAFF-R in Follicular Lymphoma: Correlation with Clinicopathologic Characteristics and Survival Outcomes
por: Li, Ya-Jun, et al.
Publicado: (2012)

Don’t Discount Societal Value in Cost-Effectiveness: Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness"
por: Hall, William
Publicado: (2017)

Editorial: CAR T-Cell Therapies in Hematologic Tumors
por: Coscia, Marta, et al.
Publicado: (2020)

Cost-effectiveness of chimeric antigen receptor T-cell therapy in adults with relapsed or refractory follicular lymphoma
por: Potnis, Kunal C., et al.
Publicado: (2022)

Dysregulation of autophagy in human follicular lymphoma is independent of overexpression of BCL-2
por: McCarthy, Aine, et al.
Publicado: (2014)

Follicular Lymphoma
por: Yavaşoğlu, İrfan
Publicado: (2015)

Follicular lymphoma
por: Leich, Ellen
Publicado: (2019)

Activated protein C: cost-effective or costly?
por: Brar, Savtaj Singh, et al.
Publicado: (2007)

ABCG2 is a Direct Transcriptional Target of Hedgehog Signaling and Involved in Stroma-Induced Drug Tolerance in Diffuse Large B-Cell Lymphoma
por: Singh, Rajesh R, et al.
Publicado: (2011)

Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R
por: Lakhotia, Rahul, et al.
Publicado: (2023)

A Generic Model for Follicular Lymphoma: Predicting Cost, Life Expectancy, and Quality-Adjusted-Life-Year Using UK Population–Based Observational Data()
por: Wang, Han-I, et al.
Publicado: (2018)

A rare face of follicular lymphoma: reverse variant of follicular lymphoma
por: Maskey, Ninu, et al.
Publicado: (2020)

Follicular Lymphoma in China: Systematic Evaluation of Follicular Lymphoma Prognostic Models
por: Li, Yanan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ui29nl4vp7a74rbptr00h0hhqo